ClinicalTrials.Veeva

Find clinical trials for Melanoma in Indianapolis, IN

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Cancer
Carcinoma
Squamous Cell Carcinoma of Head and Neck
Non-Small-Cell Lung Carcinoma
Renal Cell Carcinoma
Lung Cancer
Squamous Cell Carcinoma

Melanoma trials near Indianapolis, IN, USA:

Phase 2 Trial to Evaluate Belzupacap Sarotalocan (AU-011) Via Suprachoroidal Administration in Subjects With Primary Indeterminate Lesions and Small Choroidal Melanoma

safety, tolerability, and preliminary efficacy of belzupacap sarotalocan for the treatment of primary indeterminate lesions and small choroidal melanoma...

Active, not recruiting
Ocular Melanoma
Choroidal Melanoma
Device: Suprachoroidal Microinjector
Device: PDT Laser

Phase 2

Aura Biosciences
Aura Biosciences

Carmel, Indiana, United States and 21 other locations

Prospective, interventional multicenter study evaluating adoptive cell therapy (ACT) via infusion of LN-144 (autologous TIL) followed by interleukin...

Active, not recruiting
Metastatic Melanoma
Biological: Lifileucel

Phase 2

Iovance Biotherapeutics

Indianapolis, Indiana, United States and 56 other locations

This is a Phase 1b/2, multi-center, open label umbrella study of patients ≥12 years of age with recurrent, progressive, or refractory melanoma...

Enrolling
Melanoma
Spitzoid Melanoma
Drug: Pimasertib
Drug: Tovorafenib

Phase 1, Phase 2

Day One Biopharmaceuticals

Indianapolis, Indiana, United States and 20 other locations

drug.There are 2 parts in this trial. In one part, participants have melanoma that has come back after treatment or can't be removed by surg...

Active, not recruiting
Melanoma
Carcinoma, Non-Small- Cell Lung
Drug: carboplatin
Drug: pembrolizumab

Phase 2

Seagen
Seagen

Indianapolis, Indiana, United States and 28 other locations

This is a two-part study of pembrolizumab (MK-3475) in pediatric participants who have any of the following types of cancer:advanced melanoma...

Enrolling
Melanoma
Solid Tumor
Biological: Pembrolizumab

Phase 1, Phase 2

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

Indianapolis, Indiana, United States and 14 other locations

KB707-01 is a Phase 1, open-label, multicenter, dose escalation and expansion study to evaluate the safety and tolerability of KB707 in adults with l...

Enrolling
Melanoma Stage IV
Melanoma Stage III
Biological: KB707

Phase 1

Krystal Biotech

Indianapolis, Indiana, United States and 10 other locations

A first-in-human, Phase I, open-label, multicenter study of WTX-124 administered as monotherapy and in combination with pembrolizumab to patients wit...

Enrolling
Advanced Solid Tumor
Metastatic Solid Tumor
Drug: pembrolizumab
Drug: WTX-124

Phase 1

Werewolf Therapeutics

Indianapolis, Indiana, United States and 7 other locations

TTX-080-001 is a Phase 1, open label, dose escalation and dose expansion clinical study to determine the safety, tolerability, and recommended Phase...

Active, not recruiting
Cancer
Drug: pembrolizumab
Drug: TTX-080

Phase 1

Tizona Therapeutics

Indianapolis, Indiana, United States and 39 other locations

This is a Phase 1, First-in-Human (FIH), open-label, multicenter, dose escalation and dose expansion study to evaluate the safety, tolerability, phar...

Enrolling
NF1 Mutation
Advanced Solid Tumor
Drug: ABM-168

Phase 1

ABM Therapeutics

Indianapolis, Indiana, United States and 5 other locations

The purpose of this study is to further evaluate the efficacy and safety of niraparib in patients with locally advanced or metastatic solid tumors an...

Active, not recruiting
Melanoma
Solid Tumor
Drug: Niraparib

Phase 2

Tempus AI

Indianapolis, Indiana, United States and 79 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems